BCM
Boxer Capital Management Portfolio holdings
AUM
$457M
1-Year Est. Return
645.71%
This Fund
S&P 500
1 Year Est. Return
+645.71%
AUM
$314M
AUM Growth
+$115M
(+58%)
Holding
35
Top Buys
| 1 | +$13M | |
| 2 | +$10.4M | |
| 3 | +$8.24M | |
| 4 |
ABVX
Abivax
ABVX
|
+$7.36M |
| 5 |
Inovio Pharmaceuticals
INO
|
+$4.4M |
Top Sells
| 1 | +$16M | |
| 2 | +$15.4M | |
| 3 | +$8.23M | |
| 4 |
Replimune Group
REPL
|
+$7.42M |
| 5 |
Kymera Therapeutics
KYMR
|
+$5.09M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Nurix Therapeutics
NRIX
$1.63B
| $1.62M | 0.52% |
175,000
|
|
||
27
Avalo Therapeutics
AVTX
$333M
| $1.59M | 0.51% |
+125,000
|
|
||
28
Milestone Pharmaceuticals
MIST
$147M
| $1.33M | 0.43% |
+666,666
|
|
||
29
PepGen
PEPG
$449M
| $1.16M | 0.37% |
+250,000
|
|
||
|
LBRX
30
LB Pharmaceuticals
LBRX
$602M
| $1.11M | 0.35% |
+70,000
|
|
||
31
Instil Bio
TIL
$58.2M
| $1.08M | 0.35% |
60,700
-10,000
|
|
||
32
KalVista Pharmaceuticals
KALV
$812M
| $248K | 0.08% |
20,400
-73,000
|
|
||
|
NUVB.WS
33
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| $53.9K | 0.02% |
266,666
|
|
||
34
Surrozen Inc Warrant
SRZNW
$63.6K
| $1K | ﹤0.01% |
66,666
|
|
||
|
ITOS
35
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-825,000
|
|